Adaptimmune Therapeutics PLC
ADAPY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001621227
No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Adaptimmune Therapeutics PLC as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 79
- −10 vs. Q2 2023
- Shares held
- 148.3M
- +3.61M (+2.5%) vs. Q2 2023
- Total value
- $115.7M
- −$18.2M (−13.6%) vs. Q2 2023
- New holders
- 7
- 16 more added
- Sold out
- 17
- 24 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADAPY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $72 |
| Q4 2025 | 10 | $79.7K |
| Q3 2025 | 55 | $5.47M |
| Q2 2025 | 65 | $27.7M |
| Q1 2025 | 67 | $22.9M |
| Q4 2024 | 80 | $67.0M |
| Q3 2024 | 81 | $144.1M |
| Q2 2024 | 76 | $150.0M |
| Q1 2024 | 80 | $256.1M |
| Q4 2023 | 79 | $113.9M |
| Q3 2023 | 79 | $115.7M |
| Q2 2023 | 89 | $133.9M |
| Q1 2023 | 65 | $126.4M |
| Q4 2022 | 69 | $166.3M |
| Q3 2022 | 68 | $122.4M |
| Q2 2022 | 77 | $195.1M |
| Q1 2022 | 80 | $229.2M |
| Q4 2021 | 85 | $425.9M |
| Q3 2021 | 92 | $577.3M |
| Q2 2021 | 82 | $475.7M |
| Q1 2021 | 84 | $623.8M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Adaptimmune Therapeutics PLC; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 469 | $0 | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 92 | $72 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 100 | $78 | 0.00% | −100−50.0% | Reduced |
| HighMark Wealth Management LLC | 287 | $224 | 0.00% | −982−77.4% | Reduced |
| Carmichael Hill & Associates, Inc. | 525 | $410 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 785 | $612 | 0.00% | +30+4.0% | Added |
| Sandy Spring Bank | 1,050 | $819 | 0.00% | +1,050 | New |
| US Bancorp | 1,058 | $825 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,511 | $1.00K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 4,353 | $3.00K | 0.00% | +185+4.4% | Added |
| BNP Paribas Arbitrage, SA | 4,053 | $3.16K | 0.00% | +2,339+136.5% | Added |
| Lindbrook Capital, LLC | 4,610 | $3.60K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 5,285 | $4.12K | 0.00% | +3,367+175.5% | Added |
| Rhumbline Advisers | 5,582 | $4.35K | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 6,000 | $4.37K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,037 | $6.27K | 0.00% | −8,037−50.0% | Reduced |
| Raymond James & Associates | 10,369 | $8.09K | 0.00% | −80−0.8% | Reduced |
| Advisor Group Holdings, Inc. | 10,458 | $8.16K | 0.00% | +8,200+363.2% | Added |
| Bayesian Capital Management, LP | 10,486 | $8.18K | 0.00% | −1,100−9.5% | Reduced |
| Douglas Lane & Associates, LLC | 11,000 | $8.58K | 0.00% | −2,000−15.4% | Reduced |
| Courier Capital LLC | 12,000 | $9.36K | 0.00% | +12,000 | New |
| ProShare Advisors LLC | 13,466 | $10.5K | 0.00% | +13,466 | New |
| Independent Financial Group, LLC | 18,252 | $14.2K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 19,025 | $15.0K | 0.00% | +18,866+11,865.4% | Added |
| Qube Research & Technologies Ltd | 21,561 | $16.8K | 0.00% | −78,589−78.5% | Reduced |
| Captrust Financial Advisors | 21,924 | $17.1K | 0.00% | 00.0% | Unchanged |
| Hunter Associates Investment Management LLC | 24,000 | $20.0K | 0.00% | −1,500−5.9% | Reduced |
| HSBC Holdings PLC | 26,064 | $20.1K | 0.00% | −107−0.4% | Reduced |
| UBS Group AG | 28,334 | $22.1K | 0.00% | −2,646−8.5% | Reduced |
| Janney Montgomery Scott LLC | 30,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 29,833 | $23.3K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 30,239 | $23.6K | 0.00% | +30,239 | New |
| Prosperity Wealth Management, Inc. | 30,620 | $23.9K | 0.02% | 00.0% | Unchanged |
| Main Street Financial Solutions, LLC | 31,190 | $24.3K | 0.00% | +31,190 | New |
| Commonwealth Equity Services, LLC | 31,875 | $25.0K | 0.00% | 00.0% | Unchanged |
| X-Square Capital, LLC | 26,771 | $25.0K | 0.02% | 00.0% | Unchanged |
| Invesco Ltd. | 45,906 | $35.8K | 0.00% | +10,914+31.2% | Added |
| Barclays PLC | 50,061 | $39.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 54,745 | $42.7K | 0.00% | −5,492−9.1% | Reduced |
| Northern Trust Corp | 57,423 | $44.8K | 0.00% | −1,346−2.3% | Reduced |
| Goldman Sachs Group Inc | 57,611 | $44.9K | 0.00% | +9,534+19.8% | Added |
| Two Sigma Investments, LP | 60,074 | $46.9K | 0.00% | −50,100−45.5% | Reduced |
| Two Sigma Advisers, LP | 64,437 | $50.3K | 0.00% | −32,500−33.5% | Reduced |
| Oppenheimer & Co Inc | 68,171 | $53.2K | 0.00% | 00.0% | Unchanged |
| Black Maple Capital Management LP | 69,839 | $54.5K | 0.05% | 00.0% | Unchanged |
| CSS LLC | 90,702 | $70.7K | 0.01% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 99,349 | $77.5K | 0.02% | +99,349 | New |
| Geode Capital Management, LLC | 117,909 | $92.0K | 0.00% | 00.0% | Unchanged |
| Harbor Capital Advisors, Inc. | 134,415 | $104.8K | 0.02% | +21,899+19.5% | Added |
| Simplify Asset Management Inc. | 150,000 | $117.0K | 0.02% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 166,888 | $130.2K | 0.00% | −14,712−8.1% | Reduced |
| State Street Corp | 299,101 | $233.3K | 0.00% | +8,127+2.8% | Added |
| Millennium Management LLC | 300,061 | $234.0K | 0.00% | −351,901−54.0% | Reduced |
| Endurant Capital Management LP | 311,944 | $243.3K | 0.22% | −509,094−62.0% | Reduced |
| Key Client Fiduciary Advisors, LLC | 316,325 | $246.7K | 0.15% | −12,830−3.9% | Reduced |
| DAFNA Capital Management LLC | 351,064 | $273.8K | 0.09% | 00.0% | Unchanged |
| Rathbone Brothers plc | 432,818 | $337.6K | 0.00% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 479,764 | $374.2K | 0.22% | +479,764 | New |
| Citigroup Inc | 582,275 | $454.2K | 0.00% | +790.0% | Added |
| Redmile Group, LLC | 715,607 | $558.2K | 0.03% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,027,860 | $802.0K | 0.00% | −478,515−31.8% | Reduced |
| JPMorgan Chase & Co | 1,031,417 | $804.5K | 0.00% | −273,497−21.0% | Reduced |
| Artal Group S.A. | 1,133,775 | $884.0K | 0.04% | 00.0% | Unchanged |
| BlackRock Inc. | 1,266,124 | $987.6K | 0.00% | +103,996+8.9% | Added |
| Syncona Portfolio Ltd | 1,377,294 | $1.07M | 1.60% | 00.0% | Unchanged |
| FMR LLC | 1,733,141 | $1.35M | 0.00% | −4490.0% | Reduced |
| Morgan Stanley | 2,051,346 | $1.60M | 0.00% | −25,826−1.2% | Reduced |
| Rock Springs Capital Management LP | 2,787,845 | $2.17M | 0.06% | 00.0% | Unchanged |
| Citadel Advisors LLC | 3,549,559 | $2.77M | 0.00% | +179,476+5.3% | Added |
| Bank of America Corp | 4,697,125 | $3.66M | 0.00% | −1,2940.0% | Reduced |
| MPM Oncology Impact Management LP | 5,095,912 | $3.97M | 1.06% | 00.0% | Unchanged |
| Tang Capital Management LLC | 5,166,954 | $4.03M | 0.57% | +279,716+5.7% | Added |
| MPM Asset Management LLC | 6,287,101 | $4.90M | 2.63% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 10,423,135 | $8.13M | 0.39% | +2,065,893+24.7% | Added |
| Long Focus Capital Management, LLC | 10,963,158 | $8.55M | 1.23% | +3,150,630+40.3% | Added |
| Baker Bros. Advisors LP | 10,969,282 | $8.56M | 0.05% | 00.0% | Unchanged |
| NEA Management Company, LLC | 17,079,778 | $13.3M | 1.03% | 00.0% | Unchanged |
| Baillie Gifford & Co | 17,147,409 | $13.4M | 0.01% | −28,726−0.2% | Reduced |
| Matrix Capital Management Company, LP | 38,974,185 | $30.4M | 0.36% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −358,010−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −272,681−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −88,580−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −78,441−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −73,922−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −34,307−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −25,181−100.0% | Sold out |
| Personal Cfo Solutions, LLC | 0 | $0 | 0.00% | −19,388−100.0% | Sold out |
| Newman Dignan & Sheerar, Inc. | 0 | $0 | 0.00% | −19,364−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −16,541−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −13,166−100.0% | Sold out |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −12,060−100.0% | Sold out |
| Narwhal Capital Management | 0 | $0 | 0.00% | −10,344−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,049−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,408−100.0% | Sold out |
| Worth Asset Management, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −52−100.0% | Sold out |